These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37390009)

  • 1. Production of antigenically stable enterovirus A71 virus-like particles in
    Kingston NJ; Snowden JS; Martyna A; Shegdar M; Grehan K; Tedcastle A; Pegg E; Fox H; Macadam AJ; Martin J; Hogle JM; Rowlands DJ; Stonehouse NJ
    J Gen Virol; 2023 Jun; 104(6):. PubMed ID: 37390009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of antigenically stable enterovirus A71 virus-like particles in
    Kingston NJ; Snowden JS; Martyna A; Shegdar M; Grehan K; Tedcastle A; Pegg E; Fox H; Macadam AJ; Martin J; Hogle JM; Rowlands DJ; Stonehouse NJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsids.
    Kingston NJ; Shegdar M; Snowden JS; Fox H; Groppelli E; Macadam A; Rowlands DJ; Stonehouse NJ
    J Gen Virol; 2022 Aug; 103(8):. PubMed ID: 35997623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-Independent Production of Poliovirus Virus-like Particles in Pichia pastoris: Implications for Efficient Vaccine Development and Insights into Capsid Assembly.
    Sherry L; Swanson JJ; Grehan K; Xu H; Uchida M; Jones IM; Stonehouse NJ; Rowlands DJ
    Microbiol Spectr; 2023 Feb; 11(1):e0430022. PubMed ID: 36507670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.
    Adeyemi OO; Nicol C; Stonehouse NJ; Rowlands DJ
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Enzyme-Linked Immunosorbent Assay for Detection of the Native Conformation of Enterovirus A71.
    Kingston NJ; Grehan K; Snowden JS; Shegdar M; Fox H; Macadam AJ; Rowlands DJ; Stonehouse NJ
    mSphere; 2022 Jun; 7(3):e0008822. PubMed ID: 35642505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Molecular Biology Approaches for the Production of Poliovirus Virus-Like Particles Using
    Sherry L; Grehan K; Snowden JS; Knight ML; Adeyemi OO; Rowlands DJ; Stonehouse NJ
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32161150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
    Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L
    Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.
    Wang Z; Zhou C; Gao F; Zhu Q; Jiang Y; Ma X; Hu Y; Shi L; Wang X; Zhang C; Liu B; Shen L; Mao Q; Liu G
    Vaccine; 2021 Jul; 39(31):4296-4305. PubMed ID: 34167837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice.
    Zhang C; Ku Z; Liu Q; Wang X; Chen T; Ye X; Li D; Jin X; Huang Z
    Vaccine; 2015 May; 33(20):2335-41. PubMed ID: 25820068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.
    Shen YS; Chow YH; Fang CY; Wu SR; Chen CH; Huang MH; Liao CL; Chiang JR; Liu CC
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1121-1128. PubMed ID: 37919172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
    Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
    J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and Characterisation of Stabilised PV-3 Virus-like Particles Using
    Sherry L; Grehan K; Swanson JJ; Bahar MW; Porta C; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and performance of an enterovirus 71 virus-like-particle vaccine in nonhuman primates.
    Lim PY; Hickey AC; Jamiluddin MF; Hamid S; Kramer J; Santos R; Bossart KN; Cardosa MJ
    Vaccine; 2015 Nov; 33(44):6017-24. PubMed ID: 26271825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of hand, foot and mouth disease caused by enterovirus A71 after vaccination.
    Tang J; Zhang Z; Zhang Z; Huang H; Du T; Wang X; Yan L; Rao Q; Yang J; Wang M; Shen R; Sun Q; Jiang H
    Int J Infect Dis; 2021 Jul; 108():190-197. PubMed ID: 33737136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
    Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
    Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.